A summit was held at Walter Reed where lung cancer survivors shared their stories. Meanwhile, separate reports indicate that a new drug, ivonescimab, has shown promise in extending survival for patients with squamous cell lung cancer. The developments in lung cancer treatment and patient support were discussed at various conferences and events, including one that may have featured data from a trial in China.